Evolution of tumor invasiveness: The adaptive tumor microenvironment landscape model

Cancer Research

Volumn 71, Issue 20, 2011, Pages 6327-6337

  Lee, Hyung Ok ^a   Silva, Ariosto S ^b   Concilio, Susanna ^c   Li, Yue Sheng ^a   Slifker, Michael ^a   Gatenby, Robert A ^b   Cheng, Jonathan D ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c ARCADIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CELL PROLIFERATION; COMPUTER SIMULATION; CONTROLLED STUDY; DNA MICROARRAY; EPIGENETICS; FIBROBLAST; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MATHEMATICAL MODEL; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMPUTER SIMULATION; GENE DELETION; GENE EXPRESSION PROFILING; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEINS;

EID: 80054018075     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0304     Document Type: Article

References (43)

1. Kunz-Schughart LA, Knuechel R. Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histol Histopathol 2002;17:599-621. (Pubitemid 34411214)
2. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002;70:486-97. (Pubitemid 36194314)
3. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-9.
4. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429-47. (Pubitemid 36818244)
5. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 2005;173:10-20. (Pubitemid 39627663)
6. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-7. (Pubitemid 39551661)
7. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007;7:139-47. (Pubitemid 46160989)
8. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 2002;62:3298-307. (Pubitemid 34602428)
9. Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008;8:56-61.
10. Gatenby RA, Vincent TL. Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. Mol Cancer Ther 2003;2:919-27.
11. Gatenby RA, Vincent TL. An evolutionary model of carcinogenesis. Cancer Res 2003;63:6212-20. (Pubitemid 37255166)
12. Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 2007;97:646-53. (Pubitemid 47339892)
13. Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, Cukierman E, et al. A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 2005;170:793-802. (Pubitemid 41242111)
14. Bass MD, Roach KA, Morgan MR, Mostafavi-Pour Z, Schoen T, Muramatsu T, et al. Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix. J Cell Biol 2007;177:527-38. (Pubitemid 46718280)
15. Castello-Cros R, Khan DR, Simons J, Valianou M, Cukierman E. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins. BMC Cancer 2009;9:94.
16. Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer 2001;95:67-72.
17. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ. Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 2007;244:703-13. (Pubitemid 46148971)
18. Nichols MG, Foster TH. Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. Phys Med Biol 1994;39:2161-81. (Pubitemid 24363467)
19. Groebe K, Erz S, Mueller-Klieser W. Glucose diffusion coefficients determined from concentration profiles in EMT6 tumor spheroids incubated in radioactively labeled L-glucose. Adv Exp Med Biol 1994;361:619-25.
20. Tanaka S, Meiselman HH, Engel E, Guth PH, Furukawa O, Wenby RB, et al. Regional differences of H+, HCO3-, and CO2 diffusion through native porcine gastroduodenal mucus. Dig Dis Sci 2002;47:967-73. (Pubitemid 34439170)
21. Silva AS, Yunes JA, Gillies RJ, Gatenby RA. The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res 2009;69:2677-84.
22. Patel AA, Gawlinski ET, Lemieux SK, Gatenby RA. Acellular automaton model of early tumor growth and invasion. J Theor Biol 2001;213:315-31.
23. Casciari JJ, Sotirchos SV, Sutherland RM. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol 1992;151:386-94.
24. Anderson AR. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005;22:163-86. (Pubitemid 41511340)
25. Amatangelo MD, Bassi DE, Klein-Szanto AJ, Cukierman E. Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts. Am J Pathol 2005;167:475-88. (Pubitemid 43026103)
26. Dairkee SH, Deng G, Stampfer MR, Waldman FM, Smith HS. Selective cell culture of primary breast carcinoma. Cancer Res 1995;55:2516-9.
27. Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, et al. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res 2005;65:7775-81. (Pubitemid 41297252)
28. Cukierman E. Cell migration analyses within fibroblast-derived 3-D matrices. Methods Mol Biol 2005;294:79-93.
29. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
30. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article 3.
31. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Stat Soc B 1995;57:289-300.
32. Cho HJ, Baek KE, Park SM, Kim IK, Choi YL, Cho HJ, et al. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Clin Cancer Res 2009;15:2612-9.
33. Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol 2008;18:330-7.
34. Liu L, Sun B, Pedersen JN, Aw Yong KM, Getzenberg RH, Stone HA, et al. Probing the invasiveness of prostate cancer cells in a 3D microfabricated landscape. Proc Natl Acad Sci U S A 2011;108:6853-6.
35. Drasdo D, Hohme S. A single-cell-based model of tumor growth in vitro: monolayers and spheroids. Phys Biol 2005;2:133-47. (Pubitemid 41483079)
36. Drasdo D, Hohme S. Individual-based approaches to birth and death in avascular tumors. Math Comput Model 2003;37:1163-75. (Pubitemid 36761623)
37. Basanta D, Hatzikirou H, Deutsch A. Studying the emergence of invasiveness in tumours using game theory. Eur Phys J B 2008;63:393-7.
38. Basanta D, Ribba B, Watkin E, You B, Deutsch A. Computational analysis of the influence of the microenvironment on carcinogenesis. Math Biosci 2011;229:22-9.
39. Basanta D, Simon M, Hatzikirou H, Deutsch A. Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion. Cell Prolif 2008;41:980-7.
40. Dransart E, Olofsson B, Cherfils J. RhoGDIs revisited: novel roles in Rho regulation. Traffic 2005;6:957-66. (Pubitemid 41472455)
41. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002;62:6418-23. (Pubitemid 35364098)
42. Zhang Y, Zhang B. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 2006;66:5592-8. (Pubitemid 43927109)
43. Tapper J, Kettunen E, El-Rifai W, Seppala M, Andersson LC, Knuutila S. Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 2001;128:1-6. (Pubitemid 32655473)